MIB Agents Osteosarcoma
MIB Agents OsteoBites and osTEAo
Each week, MIB Agents talks with the leaders and innovators in osteosarcoma surgery, research, treatment and advocacy. Questions are taken during the webinar and are included in each podcast. More information is available at www.mibagents.org
Author
MIB Agents Osteosarcoma
Category
Podcast website
Latest episode
Jun 18, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Immunotherapy for Osteosarcoma - Where Do We Go From Here? Sponsored by BTG Specialty Pharmaceuticals 13.05.2022 54:37
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
The Osteosarcoma Project sponsored by BTG Specialty Pharmaceuticals 06.05.2022 58:49
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
osTEAo Debut 29.04.2022 1:19:30
Camille, Mia, Carrigan, Vicky chat about what's it like in this raw, real conversation spilling the tea on osteosarcoma, and AYA cancer.
Update on Clinical Trial Development Targeting Tumor Microenvironment in Refractory and Metastatic Osteosarcoma 22.04.2022 1:02:33
Dr. Huang is the Director of Center for Pediatric Immunotherapy in the Angie Fowler AYA Cancer Institute at UH Rainbow Babies & Children's Hospital, Professor of Pediatrics at Case Western Reserve University School of Medicine, and co-leader of Immune Oncology Program at Case Comprehensive Cancer Center. He also directs the Pediatric Hematology-Oncology Fellowship Program at UH Rainbow. Dr. Va...
Exploring the Use of a Predictive Tool for Methotrexate Clearance sponsored by BTG Specialty Pharmaceuticals 15.04.2022 1:00:53
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
A Phase 1/2 Study of ZN-c3 Plus Gemcitabine in Relapsed or Refractory Osteosarcoma 15.04.2022 55:33
Discussion of a new, early phase clinical trial for patients with metastatic osteosarcoma targeting the DNA damage repair pathway. Dr. Vishu Avutu attained his M.D. from the University of Texas Southwestern Medical School and began his research endeavors with the Pediatric Oncology Education Program at St. Jude Children’s Research Hospital; finding a passion for working with adolescents and young...
MYC Amplification as a Prognostic Biomarker in Osteosarcoma Sponsored by BTG Speciality Pharmaceuticals 01.04.2022 58:16
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
Compassionate Use of Investigational Drugs: A Strategy to Access Unapproved Therapies for Pediatric Oncology Patients Presented by BTG Speciality Pharmaceuticals 25.03.2022 59:52
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) International Randomized Controlled Trial Sponsored by BTG Specialty Pharmaceuticals 18.03.2022 58:17
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
Osteosarcoma Q&A with OsteoWarriors sponsored by BTG Specialty Pharmaceuticals 11.03.2022 58:59
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
Truths & Myths of Nutrition in Cancer sponsored by BTG Specialty Pharmaceuticals 04.03.2022 58:14
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
Amputation for OS; Patient & Surgeon Perspectives sponsored by BTG Speciality Pharmaceuticals 25.02.2022 55:55
This episode is sponsored by BTG Speciality Pharmaceuticals . BTG provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. They are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialization of pharmaceutic...
Surgical Management of Pulmonary Metastases in People with Osteosarcoma - COG Trial 18.02.2022 1:01:27
Dr. John Doski, a pediatric surgeon from the UT Health San Antonio will discuss an upcoming randomized trial comparing open and minimally invasive thorascopic surgery for pulmonary metastatic osteosarcoma.
Human Trial for OST-HER2 11.02.2022 1:00:40
Today we talk with Dr. Damon Reed from Moffit Cancer Center and Dr. Nicola Mason from University of Pennsylvania School of Veterinary Medicine about the promising results from a multi-institutional clinical trial evaluating the safety and efficacy of a recombinant Listeria to prevent metastatic disease in dogs with osteosarcoma, and how that will translate to a human trial. #cli...
Osteosarcoma Q&A with Dr. Peter Anderson and OsteoWarriors 04.02.2022 1:03:32
In this weeks Osteobites episode Dr. Pete Anderson of Cleveland Clinic, together with OsteoWarriors Andrew, Kara, and Mia, will be asking and answering your questions about Osteosarcoma.
Osteobites: Back to Activity, Rotationplasty 17.12.2021 54:08
IIn this weeks Ostoebites episode we chat with Dr. Valerae Lewis & Elise Robinson Rotationplasty and back to activity! Elise Robinson is 15 years old, an osteosarcoma survivor, MIB Agents Ambassador Agent, and MIB Agents Junior Board member. Elise was diagnosed with osteosarcoma in 2014 when she was eight years old. Elise is active in sports and brings awareness to childhood cancer, ost...
OsteoBites: Clinical Trials for Relapsed or Refractory Osteosarcoma - The OLIE Study and Beyond! 19.11.2021 1:01:12
Join Dr Filemon Dela Cruz & Dr. Julia Glade Bender as they talk about The OLIE Study - Evaluating lenvatinib in combination with chemotherapy for relapsed or refractory osteosarcoma. ...... Organization Memorial Sloan Kettering Cancer Center/MSK Kids What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Ber...
Encore, Testing & Research Directory 12.11.2021 49:45
MIB Agents Osteosarcoma Webinar Series: Alanna Church, MD of Boston Children's and Harvard Medical School and Christina Ip-Toma, MIB Scientific Advisory Board Member and lead of the MIB Testing & Research Directory, talk about navigating the Testing & Research Directory to help inform a personal treatment plan or to inform research. Christina Ip-Toma, Osteomom, and Alanna Chur...
Real Talk: What it's really like and how WE feel about Osteosarcoma. 08.11.2021 1:13:31
Osteobites: Junior Board, Like No One is Listening MIB Junior Board Osteowarriors Ally & Kara, and OsteoSiblings Annika and Valerie have an honest conversation about osteosarcoma. This session is a no-holding-back conversation about unrestricted emotions, real experiences, and new realities. #likenobodyislistening ... What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer...
Planning for Dignity and What Matters Most to You 22.10.2021 1:01:04
Paul Malley is President of Aging with Dignity, a national non-profit organization based in Tallahassee, Florida, with a mission to help individuals and their families receive the care they want in case of a serious illness. As President of Aging with Dignity, Malley coordinates the national Five Wishes advance care planning program. Created by Jim Towey, founder of Aging with Dignity and former l...
Let's Talk Fertility and Osteosarcoma 24.09.2021 55:58
Dr. Abha Gupta discusses "Fertility Preservation in Osteosarcoma Patients" with Junior Board Members Kara, Valerie, and Alexis. We talk about it ALL. Dr. Abha Gupta received her MD at the University of Toronto. She completed her pediatrics residency at Yale New Haven Children’s Hospital (New Haven, CT) and Children’s Hospital of Eastern Ontario (Ottawa) before moving back to Toronto to...
How "Hydroxychloroquine and "self-eating" works with Osteosarcoma. 17.09.2021 54:03
In this weeks Osteobites we join Dr. Andy Livingston & Dr. Nancy Gordon as they share their discussion and leading-edge research about how "Hydroxychloroquine and "self-eating" works with Osteosarcoma." After a short presentation on this research, they take questions from attendees. It's a can't miss Osteobites. Hosted by: Ann Graham OsteoWarrior and Executive Director of MIB Agents You...
Osteosarcoma Update from Dr. Huang - 2019 OutSmarting Osteosarcoma recipient 12.09.2021 1:28:21
Osteosarcoma Update from Dr. Huang - 2019 OutSmarting Osteosarcoma recipient Dr. Huang is back on OSTEOBites to give us an update on his research funded by OutSmarting Osteosarcoma 2019. Don't miss this exciting new episode, plus who doesn't love Dr. Huang? ABOUT Alex Huang, MD, PhD: Dr. Huang received a B.S. in chemistry and an M.S. in biochemistry and molecular biology from the Univ...
OsteoBites Welcomes Junior Board Members to discuss "Four OsteoWarriors' Perspectives". 30.07.2021 1:07:25
OsteoBites Welcomes Junior Board Members to discuss "Four OsteoWarriors' Perspectives". ... Brandon, Charlotte, Kara, and Maeve will be speaking about their experiences as patients and survivors. Topics include: 📌Life After Osteosarcoma, Brandon Friedman 📌Things I Wish I knew Going Into Treatment, Kara Skrubis 📌What It's Like To Be A Patient On A Clinical Trial, Charlotte Mu...
OsteoBites welcomes Dr. Moyez Jiwa to discuss "The Art of Doctoring" 23.07.2021 56:15
Dr. Jiwa is a practicing General Practitioner, Editor-in-Chief at the Journal Of Health Design, and an Associate Dean and Professor at the Melbourne Clinical School at the University of Notre Dame. From Dr. Jiwa: "I bring experience from multiple roles- clinician, researcher, publisher, innovator and leader. What my experience has taught me is that healthcare professionals can a...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.